Published in J Emerg Med on February 01, 2008
The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology (2011) 2.62
The history and future of telestroke. Nat Rev Neurol (2013) 1.03
Emergency physician and stroke specialist beliefs and expectations regarding telestroke. Stroke (2010) 1.00
Access to Expert Stroke Care with Telemedicine: REACH MUSC. Front Neurol (2012) 0.94
The chain of care enabling tPA treatment in acute ischemic stroke: a comprehensive review of organisational models. J Neurol (2012) 0.89
Stem Cells for Neurovascular Repair in Stroke. J Stem Cell Res Ther (2013) 0.83
Impact of Telemedicine on Access to Acute Stroke Care in the State of Texas. Ann Clin Transl Neurol (2014) 0.83
The effects of telemedicine on racial and ethnic disparities in access to acute stroke care. J Telemed Telecare (2015) 0.81
A one-to-one telestroke network: the first Italian study of a web-based telemedicine system for thrombolysis delivery and patient monitoring. Neurol Sci (2016) 0.77
Acute Stroke: Current Evidence-based Recommendations for Prehospital Care. West J Emerg Med (2016) 0.75
The Effect of Telemedicine on Access to Acute Stroke Care in Texas: The Story of Age Inequalities. Stroke Res Treat (2015) 0.75
Sex Disparities in Access to Acute Stroke Care: Can Telemedicine Mitigate this Effect? J Health Dispar Res Pract (2016) 0.75
Observational study of telephone consults by stroke experts supporting community tissue plasminogen activator delivery. Acad Emerg Med (2012) 0.75
Assimilation of web-based urgent stroke evaluation: a qualitative study of two networks. JMIR Med Inform (2014) 0.75
The progress of telestroke in China. Stroke Vasc Neurol (2017) 0.75
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke (2003) 4.13
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Stroke (2005) 3.74
Exploring the functional landscape of gene expression: directed search of large microarray compendia. Bioinformatics (2007) 3.59
Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med (2005) 3.38
A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57
Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke (2012) 2.46
Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association's Task Force on the Development of Stroke Systems. Circulation (2005) 2.38
Prevalence of asthma and asthma action plans in South Australia: population surveys from 1990 to 2001. Med J Aust (2003) 2.23
Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. Med J Aust (2007) 2.20
Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke. Stroke (2003) 2.17
Adverse drug events and medication errors in Australia. Int J Qual Health Care (2003) 2.03
MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer (2008) 2.01
How valid are self-reported height and weight? A comparison between CATI self-report and clinic measurements using a large cohort study. Aust N Z J Public Health (2006) 1.97
SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol (2004) 1.94
Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care (2013) 1.93
The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med (2002) 1.92
The North West Adelaide Health Study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol Perspect Innov (2006) 1.91
Targets for vascular protection after acute ischemic stroke. Stroke (2004) 1.88
The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics (2004) 1.87
Declining stroke rates in Californian children with sickle cell disease. Blood (2004) 1.83
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood (2009) 1.83
Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke (2011) 1.80
Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem (2004) 1.79
Predicting gene function in a hierarchical context with an ensemble of classifiers. Genome Biol (2008) 1.78
Sickle cell disease: the neurological complications. Ann Neurol (2002) 1.77
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer (2010) 1.75
Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study. Stroke (2010) 1.69
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci (2006) 1.69
Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques. AIDS (2012) 1.68
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood (2004) 1.66
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaques. J Infect Dis (2013) 1.57
Organized stroke care. Stroke (2006) 1.56
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood (2013) 1.52
Improving modified Rankin Scale assessment with a simplified questionnaire. Stroke (2010) 1.50
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats. BMC Neurol (2004) 1.47
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood (2006) 1.45
Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes. BMC Neurol (2007) 1.41
Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp Neurol (2004) 1.40
Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res (2004) 1.40
Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol (2006) 1.39
The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci (2005) 1.38
REACH: clinical feasibility of a rural telestroke network. Stroke (2005) 1.38
Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA. J Infect Dis (2010) 1.37
The effect of a multi-component smoking cessation intervention in African American women residing in public housing. Res Nurs Health (2007) 1.33
Rural-urban differences in acute stroke management practices: a modifiable disparity. Arch Neurol (2008) 1.33
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke. BMC Neurosci (2009) 1.33
Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke (2006) 1.31
Minocycline and tissue-type plasminogen activator for stroke: assessment of interaction potential. Stroke (2009) 1.30
Prevalence of hypertension by duration and age at exposure to the stroke belt. J Am Soc Hypertens (2010) 1.29
Minocycline for short-term neuroprotection. Pharmacotherapy (2006) 1.23
Longitudinal changes in ferritin during chronic transfusion: a report from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). J Pediatr Hematol Oncol (2002) 1.22
Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab (2008) 1.22
Application of beta regression to analyze ischemic stroke volume in NINDS rt-PA clinical trials. Neuroepidemiology (2011) 1.21
The impact of incomplete knowledge on evaluation: an experimental benchmark for protein function prediction. Bioinformatics (2009) 1.21
Directing experimental biology: a case study in mitochondrial biogenesis. PLoS Comput Biol (2009) 1.20
Do people with risky behaviours participate in biomedical cohort studies? BMC Public Health (2006) 1.20
A telestroke network enhances recruitment into acute stroke clinical trials. Stroke (2010) 1.19
Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life. Stroke (2011) 1.19
Telestroke: extending stroke expertise into underserved areas. Lancet Neurol (2006) 1.17
Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J Hypertens (2006) 1.17
Teleneurology applications: Report of the Telemedicine Work Group of the American Academy of Neurology. Neurology (2013) 1.17
Hematopoietic origin of glomerular mesangial cells. Blood (2002) 1.17
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev (2010) 1.17
Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc Natl Acad Sci U S A (2005) 1.16
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease. J Neurochem (2007) 1.15
Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog Neurobiol (2008) 1.15
Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med (2008) 1.13
Minocycline development for acute ischemic stroke. Transl Stroke Res (2011) 1.12
Genetic predictors for stroke in children with sickle cell anemia. Blood (2011) 1.12
Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients. Neurology (2010) 1.12
Behavioral and histological characterization of intrahippocampal grafts of human bone marrow-derived multipotent progenitor cells in neonatal rats with hypoxic-ischemic injury. Cell Transplant (2006) 1.10
Central obesity is associated with nonatopic but not atopic asthma in a representative population sample. J Allergy Clin Immunol (2006) 1.09
Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A (2012) 1.08